Data temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.
Investlytic score: 2/5 criteria met. Data as of 03/10/2026.
- ❌ Price trend failed
- ❌ Growth failed
- ✅ Debt passed
- ✅ P/E passed
- ❌ Correction failed
Price trend
Overall trend (8 years): insufficient progression (less than x1.5).
Price change 2018 → 2019: 73.01%
Price change 2019 → 2020: -76.22%
Price change 2020 → 2021: -4.71%
Price change 2021 → 2022: 39.43%
Price change 2022 → 2023: 14.34%
Price change 2023 → 2024: 17.03%
Price change 2024 → 2025: -4.45%
Price change 2025 → 2026: 13.73%
Price change 2026 (year to date): 11.53%
Financial growth
Revenue CAGR (8 years): -0.41%
Earnings CAGR (8 years): N/A
Growth status: insufficient data or negative trend.
Debt
Debt-to-equity ratio: 0.40
Debt/equity < 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: 8.99
P/E < 25.0 (maximum threshold).
Correction (6 months)
Current correction: 34.73% from the high over 6 months.
Excessive correction (> 20.0%).
Criteria of the Investlytic model
- / 5Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|---|---|---|---|
| Vallourec S.A. | 9.1 | 0.40 | −1.1 % | 🔒 |
| Arkema S.A. | 22.9 | 0.89 | +2.9 % | – |
| Vicat S.A. | 9.0 | 0.57 | +4.4 % | – |
| Imerys S.A. | – | 0.86 | +0.1 % | – |
| Eramet S.a. | – | 3.52 | −1.7 % | – |
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|